Patients’ Health Information and Medication Adherence in Hypertension Management at Kenyatta National Hospital; Kenya

Alembi Osanya Ayub¹, Dr Joyce C. Kirui² and Dr. Eliphas Gitonga^3,

¹Health Information Department, Kenyatta National Hospital

²Department of Health Management and Informatics, Kenyatta University

³Department of Population, Reproductive Health and Community Resource Management, Kenyatta University

Cite this paper

Alembi Osanya Ayub, Dr Joyce C. Kirui and Dr. Eliphas Gitonga. Patients’ Health Information and Medication Adherence in Hypertension Management at Kenyatta National Hospital; Kenya. American Journal of Public Health Research. 2023; 11(1):18-24. doi: 10.12691/AJPHR-11-1-4

Abstract

Background: Ministry of Health in Kenya National STEPS survey observed, 56% of Kenyans had never been checked for blood pressure, 90% of those on treatment still had their blood pressure uncontrolled and of major concern is complications of hypertension account for over 50% hospitalization and 40% of hospital mortalities [1]. Objective: This study determines Medication adherence health information needs among patients on hypertensive management at Kenyatta National Hospital; Nairobi County, Kenya. Methods: Random sampling was used to select 259 study participants. Systematic sampling was used so that every 2^nd patient from the sampling frame was interviewed, the Morisky Medication adherence scale - 8 scale was used. A descriptive cross-sectional design was used and chi-square test and logistic regression were used to analyze the data. Results: Most patients with difficulty in adhering to medication plan had raised blood pressure on clinic day. 88.7% forgot taking medicine the previous day, 71.9% stopped or changed medication dosage without consulting the doctors, 66.7% stopped or skipped using medicine whenever blood pressure was well or controlled, 57.6% feel harassed adhering to treatment plan, and 55.9% forget taking medication when travelling. Conclusion: Health Information on adherence to medication plan was found to be inadequate. Patient factors affect adherence to medication plan, patients with adherence challenges had their blood pressure outside normal ranges on the clinic day. It is recommended that the Kenya Ministry of Health and Kenyatta National hospital improve medication adherence through provision of health information on medication adherence.

Keywords

medication adherence, health information need, hypertension

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	STEPS. The STEPS survey report, Kenya, 2015. Available at http://aphrcorg/wp-content/uploads/2016/04/Steps-Report-NCD-2015pdf.Accessed on 30th July 2019.
[2]	Helena L, Aliya N, Asita de Silva H, Imtiaz J, Victoria H, Benjamin C, Saeideh T, Nantu C, et al. Patients’ experience on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: A qualitative study. PLOS one.2019; 14(1): e0211100.
[3]	Muthoni, W. (2018, November). Hypertension fast becoming Kenya’s biggest public health concern. Capital News.
[4]	Fang J, Chang T, Wang G, Loustalot F. (2020). Association between cost-related medication nonadherence and hypertension management among US adults. Am J Hypertens. 2020 May 5: hpaa072.
[5]	Reeves L, Robinson K, McClelland T, Adedoyin CA, Broeseker A, AdunlinG.Pharmacist Interventions in the Management of Blood Pressure Control and Adherence to Antihypertensive Medications: A Systematic Review of Randomized Controlled Trials. J Pharm Pract. 2020 Feb 18: 897190020903573.
[6]	Abbas H, Kurdi M, de Vries F, van Onzenoort HAW, Driessen JHM, Watfa M, Karam R. Factors Associated with Antihypertensive Medication Non-Adherence: A Cross- Sectional Study Among Lebanese Hypertensive Adults. Patient Prefer Adherence. 2020. Apr 1; 14: 663-673.
[7]	Aboyan, I., Grachev, S., Pakus, S., Pakus, D., &Shiranov, K. (2016). Mini-percutaneous nephrolithotomy. Specificities of surgical technique. Urology And Andrology, 4(3), 41-44.
[8]	Allen B, Thorwarth WT. (2014). Comments from the American College of Radiology. Washington, DC: 2014. (Input submitted to the Committee on Diagnostic Error in Health Care, November 5 and December 29, 2014).
[9]	AMA (American Medical Assocation) (2014). Improving care: Priorities to improve electronic health record usability. 2014. [February 9, 2015]. www.ama-assn.org/ama/pub/about-ama/strategic-focus​/enhancing-professional-satisfaction-and-practice-sustainability.page.
[10]	Briganti EM, Shaw JE, Chadban SJ, Zimmet PZ, Welborn TA, McNeil JJ, Atkins RC. Untreated hypertension among Australian adults: The 1999-2000 Australian diabetes, obesity and lifestyle study (AusDiab). MJA 2003; 179: 135-139.
[11]	Carayon P, Faye H, Hundt AS, Karsh BT, T. Wetterneck T. Handbook of Healthcare Delivery Systems. Yuehwern Y, editor. Boca Raton, FL: Taylor & Francis; 2011. pp. 12-1–12-15. (Patient safety and proactive risk assessment).
[12]	Chappell, F. (2015). Medication adherence in children remains a challenge. Prescriber, 26(12), 31-34.
[13]	Espeche W, Salazar MR, Sabio R, Diaz A, LeivaSisnieguez C, Olano D, Balbin E, Renna N, Grosse P, Flores RA, Lagos AC, Ferrer P, Poppe S, Risso Patron F, SotnieczukStasiuk VD, Valentini E, Cardozo JR, Romano JR, Parodi R, Carbajal H. Adherence to antihypertensive drug treatment in Argentina: A multicenter study. J ClinHypertens (Greenwich). 2020 Apr; 22(4): 656-662.
[14]	Frantz, R. (2018). Treatment Considerations for Pulmonary Arterial Hypertension and Assessment of Treatment Response. Advances In Pulmonary Hypertension, 16(3), 120-124.
[15]	Gabb GM, Mangoni A, Anderson CS, Cowley D, Dowden JS, Golledge J, et al. (2017). Guideline Hamrahian SM. Management of Hypertension in Patients with Chronic Renal Disease. Curr Hypertens Rep. 2017 May; 19(5): 43.
[16]	Garrison L, Mestre-Ferrandiz J, Zamora B. The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics. London, UK: Office of Health Economics; 2016
[17]	Huffman MD and Lloyd-Jones DM. Global burden of raised blood pressure: Coming into focus. JAMA 2017 Jan 10; 317: 142.
[18]	Hussein A, Awad MS, Mahmoud HEM. Patient adherence to antihypertensive medications in upper Egypt: a cross-sectional study. Egypt Heart J. 2020 May 25; 72(1): 29.
[19]	Institute for Health Metrics and Evaluation and the International Centre for Humanitarian Affairs. The Global Burden of Disease: Generating Evidence, Guiding Policy in Kenya. Nairobi, Kenya; 2016.
[20]	Jankowska-Polańska B, Uchmanowicz I, Dudek K, Mazur G. Relationship between patients & rsquo; knowledge and medication adherence among patients with hypertension [Internet]. Patient Preference and Adherence. 2016 [cited 2018 Dec 10]. Available from: https://www.dovepress.com/relationship-between-patientsrsquo-knowledge-andmedication-adherence--peer-reviewed-fulltext-article-PPA.
[21]	Macquart de Terline D, Kramoh KE, Bara Diop I, Nhavoto C, Balde DM, Ferreira B, Houenassi MD, Hounsou D, Ikama MS, Kane A, Kimbally-Kaki SG, Kingue S, Koffi F, Kouam Kouam C, Limbole E, Mfeukeu Kuate L, Mipinda JB, N'goran Y, Sesso Z, SidiAly A, Toure IA, Plouin PF, Azizi M, Perier MC, Narayanan K, Empana JP, Jouven X, Antignac M (2020). Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross- sectional study from 12 sub- Saharan countries. Arch Cardiovasc Dis. 2020 May 17: S1875-2136(20)30101-7.
[22]	MOH. Kenya National Guidelines for Cardiovascular Diseases management; Division of Non-Communicable Diseases, Nairobi-Kenya (2018).
[23]	Nishigaki N, Shimasaki Y, Yoshida T, Hasebe N. Physician and patient perspectives on hypertension management and factors associated with lifestyle modifications in Japan: results from an online survey. Hypertens Res. 2020 May; 43(5): 450-462.
[24]	Nishimura S, Kumamaru H, Shoji S, Sawano M, Kohsaka S, Miyata H. Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan. Hypertens Res. 2020 Jul; 43(7): 705-714.
[25]	Odedosu T, Schoenthaler A, Vieira DL, Agyemang C, Ogedegbe G. Overcoming barriers to hypertension control in African Americans. Cleve Clin J Med 2012; 79:46-56.
[26]	Rasmussen JN, Chong A & Alter DA (2017). Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007; 297: 177-186.
[27]	Sanii Y, Torkamandi H, Gholani K, Hadavand N, Javadi M. Role of pharmacist counseling in pharmacotherapy quality improvement. J Res Pharm Pract. 2016; 5(2): 132-7.
[28]	Schmieder RE. Goebel M. Bramlage P. Barriers to cardiovascular risk prevention and management in Germany—an analysis of the EURIKA study. Vasc Health Risk Manag 2012; 8: 177-186.
[29]	Shukri, F.M., Martin, K.M, Richard, W., Fredrick, W., Tilahun, H., Pamela, J., Loise, N., Catherine, K., & Elijah, O. (2018). Prevalence, awareness, treatment and control of hypertension and their determinants.BMC Public Health, 18 (Suppl 3).
[30]	Sokol MC, McGuigan KA, Verbrugge RR & Epstein RS (2015). Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005; 43: 521-530.
[31]	Tadesse M A, Shehab A, Eyob A G, Akshaya S. B, Ahmed A. E. Nonadherence to antihypertensive drugs; A systematic review and meta-analysis, Medicine (Baltimore). 2017 Jan: 96(4): e5641.
[32]	Wang K, Li Y, Liu G, Rimm E, Chan AT, Giovannucci EL, Song M. Healthy Lifestyle for Prevention of Premature Death Among Users and Nonusers of Common Preventive Medications: A Prospective Study in 2 US Cohorts. J Am Heart Assoc. 2020 Jul 7; 9(13): e016692.
[33]	White F, Wang L, Jelinek H. Awareness, and pharmacotherapy of hypertension in a rural community. Med Princ Pract 2009; 18: 261-265.
[34]	WHO. Raised blood pressure. Situation and trends. Available at http://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/. Last acc.